FORT WORTH, Texas, Aug. 11 Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) is pleased to announce the sales expansion of its advanced wound care collagen product, CellerateRX, into South Africa. With EWA Government Systems and Spiramed (Pty) Ltd., the Company has obtained the registration of the product in the region and has also obtained the necessary NAPPI codes, which are a pre-requisite for any billable health product in South Africa. In addition, CellerateRX® is registered with various South African insurance companies and is an authorized product for reimbursement. The CellerateRX® products will be distributed by Spiramed (Pty) Ltd.
Advertisement
Wound Management Technologies' subsidiary, Wound Care Innovations, LLC, has the exclusive world wide distribution rights to CellerateRX® and has a representative agreement with EWA Government Systems to engage CellerateRX® distributors in Africa and other international markets.
Advertisement
"We are pleased to be working with Wound Care Innovations, LLC and Spiramed (Pty) Ltd. to introduce CellerateRX® to the African market," stated Lynn Adcock, Director of Africa Strategic Planning, EWA Government Systems, Inc. "We have received positive responses from multiple African countries with the clinical use of this product."
"The recurring worldwide acceptance of CellerateRX® evidenced by our recent expansion into Central America and now South Africa, shows that our international sales efforts are well placed and that CellerateRX® has unique benefits in wound care," states Cathy Bradshaw, President of Wound Care Innovations. "EWA has worked diligently to get the CellerateRX® products into this market and we look forward to continued market expansion with them."
CellerateRX® is FDA approved for market for all acute and chronic wounds except 3rd degree burns.
For Wound Management Technologies Shareholder Information please call 817-820-7077 or go to http://www.wmgtech.com
About Wound Care Innovations, LLC
Wound Care Innovations, LLC (WCI) is a wholly owned subsidiary of Wound Management Technologies, Inc. (OTC Bulletin Board:WNDM.ob - News) with its corporate headquarters in Fort Worth, Texas, and regional offices in Ft. Lauderdale, Florida. WCI markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on CellerateRX®, please visit the WCI web site at http://www.CellerateRX.com/ .
About Wound Management Technologies, Inc.
Wound Management Technologies, Inc.'s primary focus is the distribution of its unique, patented collagen product, CellerateRX®, in the $3.2B worldwide advanced wound care market, a market that is growing due to aging populations and the increase of diabetes. Over the past 2 years Wound Management has focused on developing evidenced-based studies on CellerateRX® and gaining physician awareness by participation in key industry conferences. Now Wound Management is focused on expanding sales through partnerships and contracted independent representatives. Wound Management has other advanced biotech products in development for bone wax, bone void fillers and shingles pain reduction as well as a subsidiary focused on eHealth technology for secure healthcare data collaboration and storage. More information can be found on the company's web sites: http://www.wmgtech.com, http://www.CellerateRX.com , and http://www.secureehealth.com .
About EWA Government Systems, Inc.:
EWA Government Systems, Inc. (EWA GSI) provides the highest quality products and services across a broad range of technology and engineering specialties to a variety of industries including national defense, the Federal Government, law enforcement, emergency response, and healthcare. They also provide comprehensive analyses, engineering, and management services to the DoD community and to Federal and Civil agencies.
EWA GSI is represented by the finest people who continually rise above expectations to achieve extraordinary results. EWA GSI remains true in their commitment to customers both old and new, delivering innovative and enduring solutions for a competitive world.
To learn more about EWA Government Systems, Inc. please visit http://www.ewa-gsi.com
Safe Harbor Statement:
The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
For Further Information: Shareholder Relations-Communications (817)820-7077
SOURCE Wound Management Technologies, Inc.
